These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30590105)

  • 61. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease.
    Kim H; Kim SH; Cha H; Kim SR; Lee JH; Park JW
    Free Radic Res; 2016 Aug; 50(8):853-60. PubMed ID: 27142242
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism.
    Park G; Park YJ; Yang HO; Oh MS
    Pharmacol Biochem Behav; 2013 Mar; 104():163-8. PubMed ID: 23369986
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.
    Jiang H; Li LJ; Wang J; Xie JX
    Exp Neurol; 2008 Aug; 212(2):532-7. PubMed ID: 18577498
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson's disease.
    Revishchin A; Moiseenko L; Kust N; Bazhenova N; Teslia P; Panteleev D; Kovalzon V; Pavlova G
    BMC Neurosci; 2016 Jun; 17(1):34. PubMed ID: 27286696
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Defective trafficking of Kv2.1 channels in MPTP-induced nigrostriatal degeneration.
    Chao RY; Cheng CH; Wu SN; Chen PC
    J Neurochem; 2018 Feb; 144(4):483-497. PubMed ID: 29265365
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.
    Xia XG; Harding T; Weller M; Bieneman A; Uney JB; Schulz JB
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10433-8. PubMed ID: 11504916
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dopamine neuron loss by selective deletion of autophagy-related gene 5 is not exacerbated by MPTP toxicity in midbrain.
    Ren YH; Niu XY; Huang HJ; Hao XD; Wang PX; Chi YL; Ding YQ; Liao M
    Neurosci Lett; 2018 May; 675():140-144. PubMed ID: 29175031
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P; Ferger B
    Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway.
    Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson C; Wolf CR; Gama MJ
    Mol Neurobiol; 2012 Jun; 45(3):466-77. PubMed ID: 22539231
    [TBL] [Abstract][Full Text] [Related]  

  • 72. RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease.
    Dutta D; Kundu M; Mondal S; Roy A; Ruehl S; Hall DA; Pahan K
    Neurobiol Dis; 2019 Dec; 132():104575. PubMed ID: 31445159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice.
    Bian K; Liu C; Wang Y; Xue Y; Chen L
    Neurosci Lett; 2021 Nov; 765():136291. PubMed ID: 34666119
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Harpagoside attenuates MPTP/MPP⁺ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor.
    Sun X; Xiong Z; Zhang Y; Meng Y; Xu G; Xia Z; Li J; Zhang R; Ke Z; Xia Z; Hu Y
    J Neurochem; 2012 Mar; 120(6):1072-83. PubMed ID: 22192054
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.
    Xu X; Song N; Wang R; Jiang H; Xie J
    Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of estrogen and levodopa in 1-methyl-4-pheny-l-1, 2, 3, 6-tetrahydropyridine (mptp)-induced cognitive deficit in Parkinsonian ovariectomized mice model: A comparative study.
    Yadav SK; Pandey S; Singh B
    J Chem Neuroanat; 2017 Nov; 85():50-59. PubMed ID: 28711564
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-inflammatory and anti-apoptotic effects of (RS)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson's disease.
    Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
    Bioorg Med Chem; 2013 Sep; 21(17):5532-47. PubMed ID: 23810671
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deficiency of Trim27 protects dopaminergic neurons from apoptosis in the neurotoxin model of Parkinson's disease.
    Liu Y; Zhu M; Lin L; Fan X; Piao Z; Jiang X
    Brain Res; 2014 Nov; 1588():17-24. PubMed ID: 25223908
    [TBL] [Abstract][Full Text] [Related]  

  • 79. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease.
    Hu YB; Zhang YF; Wang H; Ren RJ; Cui HL; Huang WY; Cheng Q; Chen HZ; Wang G
    Cell Death Dis; 2019 Aug; 10(8):589. PubMed ID: 31383850
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice.
    Matsuo K; Cheng A; Yabuki Y; Takahata I; Miyachi H; Fukunaga K
    Neuropharmacology; 2019 May; 150():164-174. PubMed ID: 30930168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.